दुर्मिळ ब्लड कॅन्सर (BPDCN)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
कुठे जायचं
या ट्रायलसाठी भारतातील १ हॉस्पिटल रुग्णांना घेत आहे.
रजिस्ट्री सारांश (तांत्रिक)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a very rare hematologic malignancy. Despite recent advances, at present there is no consensus on the optimal treatment of BPDCN. The optimal therapy of disease remains to be determined, and due to the rarity of cases, there is a need for international collaboration to collect data on BPDCN clinical presentations, diagnostics, treatment regimens and outcomes. Therefore, the objectives of this study are: (1) to build a large database of patients with BPDCN, (2) to investigate the characteristics and outcome of the disease with different tre…
स्पॉन्सर: इम्युन ऑन्कोलॉजी रिसर्च इन्स्टिट्यूट
ClinicalTrials.gov वर NCT05430971
रजिस्ट्रीवर शेवटचे अपडेट 5 जून 2026 · आम्ही वाचले 20 ऑक्टोबर 2026